Tag: NeuMoDx™️ 96
-
RevnaBio receives FDA approval for NeuMoDx™️ 96; first in Sub-Saharan Africa
Ghana-based precision medicine company Revna Biosciences (RevnaBio) has received historic approval from the Food and Drugs Authority of Ghana (FDA) to use the NeuMoDx™️ 96 diagnostics platform supplied by the global biotech company QIAGEN. The registration comes in addition to FDA permissions for RevnaBio to conduct its first set of complex tests for the Ghanaian/West…